Hsd:WI |
serum total protein level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood total protein amount |
male |
119 days-126 days |
6 |
8.68 |
g/dl |
0.78 |
1.9 |
liquid phase colorimetry |
0.0 |
0 |
76126 |
1545 |
Hsd:WI |
serum calcium level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood calcium amount |
male |
119 days-126 days |
5 |
12.82 |
mg/dl |
0.24 |
0.53 |
liquid phase colorimetry |
0.0 |
0 |
76141 |
1545 |
Hsd:WI |
serum albumin level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood albumin amount |
male |
119 days-126 days |
5 |
0.04 |
g/dl |
0.0 |
0.0 |
liquid phase colorimetry |
0.0 |
0 |
76149 |
1545 |
Hsd:WI |
serum albumin level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood albumin amount |
male |
119 days-126 days |
6 |
0.05 |
g/dl |
0.0 |
0.01 |
liquid phase colorimetry |
0.0 |
0 |
76150 |
1545 |
Hsd:WI |
serum creatinine level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood creatinine amount |
male |
119 days-126 days |
6 |
0.65 |
mg/dl |
0.03 |
0.08 |
liquid phase colorimetry |
0.0 |
0 |
76171 |
1545 |
Hsd:WI |
plasma creatinine level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood creatinine amount |
male |
0 days
| 8 |
1.67 |
mg/dl |
0.12 |
0.33 |
liquid phase colorimetry |
0.0 |
0 |
75946 |
1542 |
Hsd:WI |
plasma uric acid level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood uric acid amount |
male |
0 days
| 8 |
4.89 |
mg/dl |
0.35 |
0.98 |
liquid phase colorimetry |
0.0 |
0 |
75950 |
1542 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
450.1 |
U/mg |
3.15 |
8.91 |
liquid phase colorimetry |
0.0 |
0 |
76201 |
1542 |
Hsd:WI |
kidney catalase activity to total protein level ratio |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
catalase activity |
male |
0 days
| 6 |
21.73 |
nmol/mg |
0.62 |
1.51 |
liquid phase colorimetry |
0.0 |
0 |
76235 |
1544 |
Hsd:WI |
kidney glutathione peroxidase activity to glutathione reductase activity ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione peroxidase activity |
male |
0 days
| 8 |
62.54 |
null |
2.21 |
6.24 |
liquid phase colorimetry |
0.0 |
0 |
76215 |
1542 |
Hsd:WI |
kidney superoxide dismutase to catalase activity ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
6.67 |
null |
0.3 |
0.85 |
liquid phase colorimetry |
0.0 |
0 |
76219 |
1542 |
Hsd:WI |
plasma urea nitrogen level |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood urea nitrogen amount |
male |
0 days
| 8 |
8.05 |
mmol/l |
0.44 |
1.25 |
liquid phase colorimetry |
0.0 |
0 |
75940 |
1542 |
Hsd:WI |
serum total cholesterol level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood cholesterol amount |
male |
119 days-126 days |
5 |
68.12 |
mg/dl |
6.42 |
14.36 |
liquid phase colorimetry |
0.0 |
0 |
76130 |
1545 |
Hsd:WI |
serum urea nitrogen level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood urea nitrogen amount |
male |
119 days-126 days |
6 |
80.85 |
mg/dl |
3.23 |
7.92 |
liquid phase colorimetry |
0.0 |
0 |
76165 |
1545 |
Hsd:WI |
serum urea nitrogen level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood urea nitrogen amount |
male |
119 days-126 days |
6 |
76.42 |
mg/dl |
4.07 |
9.96 |
liquid phase colorimetry |
0.0 |
0 |
76167 |
1545 |
Hsd:WI |
kidney glutathione level |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione amount |
male |
0 days
| 6 |
10012.49 |
ug/g |
293.58 |
719.13 |
liquid phase colorimetry |
0.0 |
0 |
76240 |
1544 |
Hsd:WI |
kidney glutathione peroxidase activity to glutathione reductase activity ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione peroxidase activity |
male |
0 days
| 8 |
46.14 |
null |
1.7 |
4.82 |
liquid phase colorimetry |
0.0 |
0 |
76216 |
1542 |
Hsd:WI |
kidney superoxide dismutase to catalase activity ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
1.93 |
null |
0.07 |
0.2 |
liquid phase colorimetry |
0.0 |
0 |
76218 |
1542 |
Hsd:WI |
kidney superoxide dismutase to catalase activity ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
2.92 |
null |
0.11 |
0.32 |
liquid phase colorimetry |
0.0 |
0 |
76220 |
1542 |
Hsd:WI |
serum urea nitrogen level |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood urea nitrogen amount |
male |
0 days
| 6 |
89.7 |
mg/dl |
2.9 |
7.11 |
liquid phase colorimetry |
0.0 |
0 |
75978 |
1544 |
Hsd:WI |
kidney glutathione peroxidase activity to total protein level ratio |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione peroxidase activity |
male |
0 days
| 6 |
22.63 |
U/mg |
1.35 |
3.3 |
liquid phase colorimetry |
0.0 |
0 |
76191 |
1544 |
Hsd:WI |
kidney glutathione peroxidase activity to total protein level ratio |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione peroxidase activity |
male |
0 days
| 6 |
7.54 |
U/mg |
0.51 |
1.24 |
liquid phase colorimetry |
0.0 |
0 |
76192 |
1544 |
Hsd:WI |
kidney glutathione peroxidase activity to total protein level ratio |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione peroxidase activity |
male |
0 days
| 6 |
15.4 |
U/mg |
0.29 |
0.71 |
liquid phase colorimetry |
0.0 |
0 |
76194 |
1544 |
Hsd:WI |
serum total protein level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood total protein amount |
male |
119 days-126 days |
5 |
9.38 |
g/dl |
0.67 |
1.5 |
liquid phase colorimetry |
0.0 |
0 |
76125 |
1545 |
Hsd:WI |
serum total cholesterol level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood cholesterol amount |
male |
119 days-126 days |
6 |
66.62 |
mg/dl |
5.62 |
13.77 |
liquid phase colorimetry |
0.0 |
0 |
76131 |
1545 |
Hsd:WI |
plasma urea nitrogen level |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood urea nitrogen amount |
male |
0 days
| 8 |
8.7 |
mmol/l |
0.47 |
1.34 |
liquid phase colorimetry |
0.0 |
0 |
75939 |
1542 |
Hsd:WI |
serum triglyceride level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood triglyceride amount |
male |
119 days-126 days |
6 |
116.97 |
mg/dl |
7.02 |
17.2 |
liquid phase colorimetry |
0.0 |
0 |
76136 |
1545 |
Hsd:WI |
serum calcium level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood calcium amount |
male |
119 days-126 days |
6 |
12.93 |
mg/dl |
0.78 |
1.91 |
liquid phase colorimetry |
0.0 |
0 |
76142 |
1545 |
Hsd:WI |
serum albumin level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood albumin amount |
male |
119 days-126 days |
6 |
0.04 |
g/dl |
0.0 |
0.0 |
liquid phase colorimetry |
0.0 |
0 |
76153 |
1545 |
Hsd:WI |
serum total bilirubin level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood bilirubin amount |
male |
119 days-126 days |
6 |
0.75 |
mg/dl |
0.26 |
0.64 |
liquid phase colorimetry |
0.0 |
0 |
76158 |
1545 |
Hsd:WI |
serum urea nitrogen level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood urea nitrogen amount |
male |
119 days-126 days |
6 |
72.18 |
mg/dl |
5.06 |
12.4 |
liquid phase colorimetry |
0.0 |
0 |
76168 |
1545 |
Hsd:WI |
serum creatinine level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood creatinine amount |
male |
119 days-126 days |
6 |
0.65 |
mg/dl |
0.03 |
0.08 |
liquid phase colorimetry |
0.0 |
0 |
76172 |
1545 |
Hsd:WI |
serum lactate dehydrogenase activity level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood lactate dehydrogenase amount |
male |
119 days-126 days |
5 |
1068.0 |
U/l |
313.23 |
700.4 |
liquid phase colorimetry |
0.0 |
0 |
76177 |
1545 |
Hsd:WI |
plasma creatinine level |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood creatinine amount |
male |
0 days
| 8 |
0.31 |
mg/dl |
0.02 |
0.05 |
liquid phase colorimetry |
0.0 |
0 |
75943 |
1542 |
Hsd:WI |
kidney paraoxonase1 activity to total protein level ratio |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney paraoxonase 1 activity |
male |
0 days
| 8 |
17.25 |
U/mg |
0.61 |
1.73 |
liquid phase colorimetry |
0.0 |
0 |
76209 |
1542 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
242.2 |
U/mg |
5.3 |
15.0 |
liquid phase colorimetry |
0.0 |
0 |
76200 |
1542 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney superoxide dismutase activity |
male |
0 days
| 6 |
11.74 |
U/mg |
0.56 |
1.38 |
liquid phase colorimetry |
0.0 |
0 |
76190 |
1544 |
Hsd:WI |
kidney superoxide dismutase to paraoxonase1 activity ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
47.04 |
null |
2.0 |
5.65 |
liquid phase colorimetry |
0.0 |
0 |
76227 |
1542 |
Hsd:WI |
serum creatinine level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood creatinine amount |
male |
119 days-126 days |
5 |
0.68 |
mg/dl |
0.05 |
0.11 |
liquid phase colorimetry |
0.0 |
0 |
76170 |
1545 |
Hsd:WI |
serum lactate dehydrogenase activity level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood lactate dehydrogenase amount |
male |
119 days-126 days |
6 |
754.8 |
U/l |
112.47 |
275.5 |
liquid phase colorimetry |
0.0 |
0 |
76178 |
1545 |
Hsd:WI |
serum lactate dehydrogenase activity level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood lactate dehydrogenase amount |
male |
119 days-126 days |
6 |
919.2 |
U/l |
186.98 |
458.0 |
liquid phase colorimetry |
0.0 |
0 |
76181 |
1545 |
Hsd:WI |
kidney catalase activity to total protein level ratio |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
catalase activity |
male |
0 days
| 6 |
35.98 |
nmol/mg |
0.81 |
1.98 |
liquid phase colorimetry |
0.0 |
0 |
76234 |
1544 |
Hsd:WI |
kidney glutathione level |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione amount |
male |
0 days
| 8 |
126.5 |
ug/g |
1.5 |
4.23 |
liquid phase colorimetry |
0.0 |
0 |
76230 |
1542 |
Hsd:WI |
serum total protein level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood total protein amount |
male |
119 days-126 days |
6 |
8.18 |
g/dl |
0.21 |
0.52 |
liquid phase colorimetry |
0.0 |
0 |
76128 |
1545 |
Hsd:WI |
serum total cholesterol level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood cholesterol amount |
male |
119 days-126 days |
6 |
56.48 |
mg/dl |
4.25 |
10.4 |
liquid phase colorimetry |
0.0 |
0 |
76132 |
1545 |
Hsd:WI |
kidney glutathione peroxidase activity to total protein level ratio |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione peroxidase activity |
male |
0 days
| 6 |
13.39 |
U/mg |
0.09 |
0.21 |
liquid phase colorimetry |
0.0 |
0 |
76193 |
1544 |
Hsd:WI |
kidney lipid peroxide level |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney lipid peroxide amount |
male |
0 days
| 6 |
0.75 |
nmol/mg |
0.02 |
0.04 |
liquid phase colorimetry |
0.0 |
0 |
76256 |
1544 |
Hsd:WI |
kidney paraoxonase1 activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney paraoxonase 1 activity |
male |
0 days
| 8 |
9.57 |
U/mg |
0.3 |
0.86 |
liquid phase colorimetry |
0.0 |
0 |
76211 |
1542 |
Hsd:WI |
serum calcium level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood calcium amount |
male |
119 days-126 days |
6 |
12.98 |
mg/dl |
0.42 |
1.04 |
liquid phase colorimetry |
0.0 |
0 |
76144 |
1545 |
Hsd:WI |
serum total bilirubin level |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood bilirubin amount |
male |
119 days-126 days |
6 |
0.6 |
mg/dl |
0.13 |
0.32 |
liquid phase colorimetry |
0.0 |
0 |
76157 |
1545 |
Hsd:WI |
serum total bilirubin level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood bilirubin amount |
male |
119 days-126 days |
6 |
0.55 |
mg/dl |
0.08 |
0.21 |
liquid phase colorimetry |
0.0 |
0 |
76160 |
1545 |
Hsd:WI |
serum lactate dehydrogenase activity level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood lactate dehydrogenase amount |
male |
119 days-126 days |
6 |
1036.8 |
U/l |
158.11 |
387.3 |
liquid phase colorimetry |
0.0 |
0 |
76179 |
1545 |
Hsd:WI |
kidney glutathione level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione amount |
male |
0 days
| 8 |
108.4 |
ug/g |
4.56 |
12.9 |
liquid phase colorimetry |
0.0 |
0 |
76232 |
1542 |
Hsd:WI |
serum urea nitrogen level |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood urea nitrogen amount |
male |
0 days
| 6 |
69.64 |
mg/dl |
2.5 |
6.12 |
liquid phase colorimetry |
0.0 |
0 |
75976 |
1544 |
Hsd:WI |
serum urea nitrogen level |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood urea nitrogen amount |
male |
0 days
| 6 |
75.2 |
mg/dl |
2.16 |
5.3 |
liquid phase colorimetry |
0.0 |
0 |
75979 |
1544 |
Hsd:WI |
kidney superoxide dismutase to paraoxonase1 activity ratio |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
13.88 |
null |
0.5 |
1.41 |
liquid phase colorimetry |
0.0 |
0 |
76225 |
1542 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
292.4 |
U/mg |
14.25 |
40.3 |
liquid phase colorimetry |
0.0 |
0 |
76202 |
1542 |
Hsd:WI |
kidney catalase activity to total protein level ratio |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
catalase activity |
male |
0 days
| 6 |
23.2 |
nmol/mg |
0.29 |
0.7 |
liquid phase colorimetry |
0.0 |
0 |
76236 |
1544 |
Hsd:WI |
serum calcium level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood calcium amount |
male |
119 days-126 days |
6 |
11.98 |
mg/dl |
0.18 |
0.45 |
liquid phase colorimetry |
0.0 |
0 |
76143 |
1545 |
Hsd:WI |
serum total bilirubin level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood bilirubin amount |
male |
119 days-126 days |
6 |
0.53 |
mg/dl |
0.08 |
0.21 |
liquid phase colorimetry |
0.0 |
0 |
76159 |
1545 |
Hsd:WI |
kidney glutathione level |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione amount |
male |
0 days
| 6 |
12385.0 |
ug/g |
257.2 |
630.01 |
liquid phase colorimetry |
0.0 |
0 |
76238 |
1544 |
Hsd:WI |
kidney lipid peroxide level |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney lipid peroxide amount |
male |
0 days
| 6 |
1.51 |
nmol/mg |
0.03 |
0.08 |
liquid phase colorimetry |
0.0 |
0 |
76257 |
1544 |
Hsd:WI |
kidney superoxide dismutase to glutathione peroxidase ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
35.78 |
null |
1.46 |
4.14 |
liquid phase colorimetry |
0.0 |
0 |
76223 |
1542 |
Hsd:WI |
kidney superoxide dismutase to paraoxonase1 activity ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
19.72 |
null |
0.82 |
2.31 |
liquid phase colorimetry |
0.0 |
0 |
76228 |
1542 |
Hsd:WI |
serum total protein level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood total protein amount |
male |
119 days-126 days |
6 |
7.12 |
g/dl |
0.19 |
0.45 |
liquid phase colorimetry |
0.0 |
0 |
76127 |
1545 |
Hsd:WI |
kidney lipid peroxide level |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney lipid peroxide amount |
male |
0 days
| 6 |
0.83 |
nmol/mg |
0.04 |
0.09 |
liquid phase colorimetry |
0.0 |
0 |
76258 |
1544 |
Hsd:WI |
plasma uric acid level |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood uric acid amount |
male |
0 days
| 8 |
2.79 |
mg/dl |
0.18 |
0.52 |
liquid phase colorimetry |
0.0 |
0 |
75948 |
1542 |
Hsd:WI |
kidney catalase activity to total protein level ratio |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
catalase activity |
male |
0 days
| 6 |
30.56 |
nmol/mg |
0.37 |
0.9 |
liquid phase colorimetry |
0.0 |
0 |
76237 |
1544 |
Hsd:WI |
serum triglyceride level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood triglyceride amount |
male |
119 days-126 days |
5 |
156.94 |
mg/dl |
14.93 |
33.39 |
liquid phase colorimetry |
0.0 |
0 |
76135 |
1545 |
Hsd:WI |
serum triglyceride level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood triglyceride amount |
male |
119 days-126 days |
6 |
109.72 |
mg/dl |
16.57 |
40.58 |
liquid phase colorimetry |
0.0 |
0 |
76138 |
1545 |
Hsd:WI |
serum triglyceride level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood triglyceride amount |
male |
119 days-126 days |
6 |
111.38 |
mg/dl |
14.75 |
36.14 |
liquid phase colorimetry |
0.0 |
0 |
76139 |
1545 |
Hsd:WI |
serum albumin level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood albumin amount |
male |
119 days-126 days |
6 |
0.05 |
g/dl |
0.0 |
0.0 |
liquid phase colorimetry |
0.0 |
0 |
76152 |
1545 |
Hsd:WI |
serum lactate dehydrogenase activity level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood lactate dehydrogenase amount |
male |
119 days-126 days |
6 |
659.2 |
U/l |
70.1 |
171.7 |
liquid phase colorimetry |
0.0 |
0 |
76180 |
1545 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
239.5 |
U/mg |
7.28 |
20.6 |
liquid phase colorimetry |
0.0 |
0 |
76199 |
1542 |
Hsd:WI |
kidney superoxide dismutase to glutathione peroxidase ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
8.49 |
null |
0.4 |
1.14 |
liquid phase colorimetry |
0.0 |
0 |
76222 |
1542 |
Hsd:WI |
kidney superoxide dismutase to glutathione peroxidase ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
18.63 |
null |
0.61 |
1.73 |
liquid phase colorimetry |
0.0 |
0 |
76224 |
1542 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney superoxide dismutase activity |
male |
0 days
| 6 |
13.53 |
U/mg |
0.8 |
1.97 |
liquid phase colorimetry |
0.0 |
0 |
76187 |
1544 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney superoxide dismutase activity |
male |
0 days
| 6 |
10.11 |
U/mg |
0.22 |
0.54 |
liquid phase colorimetry |
0.0 |
0 |
76189 |
1544 |
Hsd:WI |
plasma urea nitrogen level |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood urea nitrogen amount |
male |
0 days
| 8 |
20.62 |
mmol/l |
1.27 |
3.61 |
liquid phase colorimetry |
0.0 |
0 |
75941 |
1542 |
Hsd:WI |
plasma uric acid level |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood uric acid amount |
male |
0 days
| 8 |
7.67 |
mg/dl |
0.55 |
1.55 |
liquid phase colorimetry |
0.0 |
0 |
75949 |
1542 |
Hsd:WI |
serum total cholesterol level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood cholesterol amount |
male |
119 days-126 days |
6 |
61.15 |
mg/dl |
2.86 |
7.0 |
liquid phase colorimetry |
0.0 |
0 |
76134 |
1545 |
Hsd:WI |
serum triglyceride level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood triglyceride amount |
male |
119 days-126 days |
6 |
92.87 |
mg/dl |
11.85 |
29.03 |
liquid phase colorimetry |
0.0 |
0 |
76137 |
1545 |
Hsd:WI |
serum calcium level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood calcium amount |
male |
119 days-126 days |
6 |
12.68 |
mg/dl |
0.31 |
0.76 |
liquid phase colorimetry |
0.0 |
0 |
76145 |
1545 |
Hsd:WI |
serum total bilirubin level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood bilirubin amount |
male |
119 days-126 days |
5 |
0.96 |
mg/dl |
0.07 |
0.17 |
liquid phase colorimetry |
0.0 |
0 |
76156 |
1545 |
Hsd:WI |
kidney lipid peroxide level |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney lipid peroxide amount |
male |
0 days
| 6 |
0.88 |
nmol/mg |
0.02 |
0.06 |
liquid phase colorimetry |
0.0 |
0 |
76259 |
1544 |
Hsd:WI |
kidney glutathione peroxidase activity to glutathione reductase activity ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione peroxidase activity |
male |
0 days
| 8 |
54.88 |
null |
1.74 |
4.93 |
liquid phase colorimetry |
0.0 |
0 |
76214 |
1542 |
Hsd:WI |
kidney superoxide dismutase to paraoxonase1 activity ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
12.45 |
null |
0.43 |
1.23 |
liquid phase colorimetry |
0.0 |
0 |
76226 |
1542 |
Hsd:WI |
serum total protein level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood total protein amount |
male |
119 days-126 days |
6 |
7.37 |
g/dl |
0.12 |
0.29 |
liquid phase colorimetry |
0.0 |
0 |
76129 |
1545 |
Hsd:WI |
serum urea nitrogen level |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood urea nitrogen amount |
male |
119 days-126 days |
5 |
77.76 |
mg/dl |
3.18 |
7.11 |
liquid phase colorimetry |
0.0 |
0 |
76164 |
1545 |
Hsd:WI |
serum urea nitrogen level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood urea nitrogen amount |
male |
119 days-126 days |
6 |
72.5 |
mg/dl |
4.18 |
10.25 |
liquid phase colorimetry |
0.0 |
0 |
76166 |
1545 |
Hsd:WI |
serum creatinine level |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood creatinine amount |
male |
119 days-126 days |
6 |
0.68 |
mg/dl |
0.03 |
0.08 |
liquid phase colorimetry |
0.0 |
0 |
76174 |
1545 |
Hsd:WI |
kidney paraoxonase1 activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney paraoxonase 1 activity |
male |
0 days
| 8 |
14.83 |
U/mg |
0.43 |
1.21 |
liquid phase colorimetry |
0.0 |
0 |
76212 |
1542 |
Hsd:WI |
kidney superoxide dismutase to catalase activity ratio |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
1.98 |
null |
0.07 |
0.21 |
liquid phase colorimetry |
0.0 |
0 |
76217 |
1542 |
Hsd:WI |
kidney paraoxonase1 activity to total protein level ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney paraoxonase 1 activity |
male |
0 days
| 8 |
19.45 |
U/mg |
0.75 |
2.13 |
liquid phase colorimetry |
0.0 |
0 |
76210 |
1542 |
Hsd:WI |
kidney glutathione level |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione amount |
male |
0 days
| 6 |
7882.76 |
ug/g |
178.16 |
436.39 |
liquid phase colorimetry |
0.0 |
0 |
76239 |
1544 |
Hsd:WI |
plasma creatinine level |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood creatinine amount |
male |
0 days
| 8 |
2.85 |
mg/dl |
0.25 |
0.71 |
liquid phase colorimetry |
0.0 |
0 |
75945 |
1542 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney superoxide dismutase activity |
male |
0 days
| 6 |
8.13 |
U/mg |
0.79 |
1.94 |
liquid phase colorimetry |
0.0 |
0 |
76188 |
1544 |
Hsd:WI |
serum urea nitrogen level |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood urea nitrogen amount |
male |
0 days
| 6 |
96.11 |
mg/dl |
1.91 |
4.69 |
liquid phase colorimetry |
0.0 |
0 |
75977 |
1544 |
Hsd:WI |
kidney superoxide dismutase to glutathione peroxidase ratio |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
8.66 |
null |
0.41 |
1.15 |
liquid phase colorimetry |
0.0 |
0 |
76221 |
1542 |
Hsd:WI |
kidney glutathione level |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione amount |
male |
0 days
| 8 |
123.7 |
ug/g |
1.78 |
5.04 |
liquid phase colorimetry |
0.0 |
0 |
76229 |
1542 |
Hsd:WI |
kidney glutathione level |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione amount |
male |
0 days
| 8 |
58.72 |
ug/g |
3.78 |
10.7 |
liquid phase colorimetry |
0.0 |
0 |
76231 |
1542 |
Hsd:WI |
kidney glutathione level |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione amount |
male |
0 days
| 6 |
9864.97 |
ug/g |
200.74 |
491.71 |
liquid phase colorimetry |
0.0 |
0 |
76241 |
1544 |
Hsd:WI |
plasma urea nitrogen level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood urea nitrogen amount |
male |
0 days
| 8 |
14.48 |
mmol/l |
0.88 |
2.49 |
liquid phase colorimetry |
0.0 |
0 |
75942 |
1542 |
Hsd:WI |
plasma creatinine level |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood creatinine amount |
male |
0 days
| 8 |
0.27 |
mg/dl |
0.02 |
0.05 |
liquid phase colorimetry |
0.0 |
0 |
75944 |
1542 |
Hsd:WI |
plasma uric acid level |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood uric acid amount |
male |
0 days
| 8 |
2.97 |
mg/dl |
0.18 |
0.51 |
liquid phase colorimetry |
0.0 |
0 |
75947 |
1542 |
Hsd:WI |
serum albumin level |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood albumin amount |
male |
119 days-126 days |
6 |
0.04 |
g/dl |
0.0 |
0.0 |
liquid phase colorimetry |
0.0 |
0 |
76151 |
1545 |
Hsd:WI |
serum creatinine level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood creatinine amount |
male |
119 days-126 days |
6 |
0.55 |
mg/dl |
0.04 |
0.11 |
liquid phase colorimetry |
0.0 |
0 |
76173 |
1545 |
Hsd:WI |
serum total cholesterol level |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
blood cholesterol amount |
male |
119 days-126 days |
6 |
62.85 |
mg/dl |
3.03 |
7.43 |
liquid phase colorimetry |
0.0 |
0 |
76133 |
1545 |
Hsd:WI |
kidney glutathione peroxidase activity to glutathione reductase activity ratio |
phosphate buffered saline (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione peroxidase activity |
male |
0 days
| 8 |
59.12 |
null |
1.93 |
5.47 |
liquid phase colorimetry |
0.0 |
0 |
76213 |
1542 |